XML 102 R28.htm IDEA: XBRL DOCUMENT v3.25.0.1
Insider Trading Arrangements - Officer Trading Arrangement [Member]
 3 Months Ended 12 Months Ended
Dec. 31, 2024
shares
Dec. 31, 2024
shares
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
During the fiscal quarter ended December 31, 2024, none of our directors or officers adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Item 408 of Regulation S-K, except as described in the table below:

Name and Title of InsiderAdoption, Modification or TerminationApplicable DateDuration of Trading Arrangement
Rule 10b5-1 Trading Arrangement?
(Y / N) (1)
Aggregate Number of Securities Subject to the Trading Arrangement
Melissa Baird, Chief Operating Officer
Adoption11/26/2024
4/9/2025 - 9/17/2025
Y400,000
Patrick H. Carroll, M.D., Chief Medical Officer and Director
Adoption11/08/2024
3/17/2025 - 11/14/2025
Y33,222
______________
(1)Denotes whether the trading plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) when adopted.
Non-Rule 10b5-1 Arrangement Adopted false  
Rule 10b5-1 Arrangement Terminated false  
Non-Rule 10b5-1 Arrangement Terminated false  
Melissa Baird [Member]    
Trading Arrangements, by Individual    
Name Melissa Baird  
Title Chief Operating Officer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date 11/26/2024  
Expiration Date 9/17/2025  
Arrangement Duration 161 days  
Aggregate Available 400,000 400,000
Patrick H. Carroll [Member]    
Trading Arrangements, by Individual    
Name Patrick H. Carroll, M.D.  
Title Chief Medical Officer and Director  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date 11/08/2024  
Expiration Date 11/14/2025  
Arrangement Duration 242 days  
Aggregate Available 33,222 33,222